Ryvu Therapeutics publishes research revealing potential drug combination for colorectal cancer
August 1, 2025Medical Communications, Research and Development Oncology, Ryvu Therapeutics, colorectal cancer
Ryvu Therapeutics has published new findings from its ONCO Prime target discovery platform in Scientific Reports. The study reveals a …
ESTEVE expands into US market with acquisition of Regis Technologies
August 1, 2025Mergers and Acquisitions Corporate, ESTEVE, Pharmacy, Regis Technologies, US pharma market, contract development and manufacturing organisation
ESTEVE (Esteve QuÃmica), based in Barcelona, Spain, has acquired Regis Technologies, a contract development and manufacturing organisation (CDMO) based in …
Richmond Pharmacology appoints Priscilla Ochuba as associate medical director
August 1, 2025Research and Development Contract Research Organsation, Corporate, Pharmacy, Richmond Pharmacology, associate medical director
Richmond Pharmacology has announced the promotion of Priscilla Ochuba to associate medical director, effective 1 August 2025. The move recognises …
Labguru and Titian Software rebrand as Cenevo to accelerate connected labs
July 31, 2025Analytical & Laboratory Services, Research and Development Cenevo, Corporate, Labguru, Laboratory management
Lab management companies, Labguru and Titian Software, have rebranded under a new unified name, Cenevo. This combines their solutions, Mosaic …
Hansa Biopharma bolsters leadership team with new executive appointments
July 31, 2025Research and Development Chief Human Resources Officer, Chief Legal Officer, Corporate, Executive Leadership Team, Hansa Biopharma, Vice President Corporate Affairs
Hansa Biopharma has announced three senior leadership appointments to support its global expansion as well as pre-commercial activities in the …
BioDuro and Atombeat partner to accelerate AI-powered peptide drug discovery
July 31, 2025Mergers and Acquisitions AI, BioDuro, Corporate, Devices
BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …
Key strategies to foster digital transformation in the NHS
July 30, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Visions4Health, digital transformation, pharmacy
In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …
NICE approves AstraZeneca’s dual immunotherapy for advanced liver cancer
July 30, 2025Medical Communications, Research and Development AstraZeneca, NHS, National Institute for Health and Care Excellence, Oncology, dual immunotherapy, hepatocellular carcinoma, liver cancer
AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence (NICE) for its dual immunotherapy …
Clinisys acquires Orchard Software to expand laboratory informatics leadership
July 30, 2025Analytical & Laboratory Services, Mergers and Acquisitions, Research and Development Clinisys, Corporate, Francisco Partners, Orchard Software, laboratory informatics, laboratory information management systems
Clinisys has announced the acquisition of Orchard Software from Francisco Partners, strengthening its position in laboratory informatics. The strategic acquisition …
Roche receives CE Mark for blood test to help rule out Alzheimer’s
July 30, 2025Research and Development Alzheimer's disease, CE Mark approval, Eli Lilly, Neurology, Roche
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in vitro diagnostic regulation-certified blood-based diagnostic …
Sanofi’s Sarclisa gains EU approval for multiple myeloma treatment
July 30, 2025Medical Communications, Research and Development European Commission, Oncology, Sanofi, Sarclisa, european union, multiple myeloma
Sanofi has received approval from the European Commission for the use of Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and …
ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development
July 29, 2025Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer
ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …
Relief Therapeutics to merge with NeuroX to create AI-driven neurohealth company
July 29, 2025Mergers and Acquisitions, Research and Development AI, Corporate, MindMaze, Neurology, Relief Therapeutics, neurological conditions
Relief Therapeutics has announced that it will combine with NeuroX Group, the successor to digital neurotherapeutics company MindMaze. The transaction …
Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology
July 29, 2025Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health
Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …
Mental health medicine use in England reaches record high, NHSBSA report reveals
July 29, 2025Manufacturing and Production, Medical Communications, Research and Development ADHD, COVID-19, NHS Business Services Authority, Psychiatry, antidepressants, antipsychotics, anxiolytics, barbiturate, dementia, hypnotics, mental health
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …
Bristol Myers Squibb appoints Cristian Massacesi as chief medical officer and head of development
July 28, 2025Research and Development Bristol Myer Squibb, Corporate, Executive Leadership Team, Head of Development, chief medical officer, executive vice president
Bristol Myers Squibb (BMS) has announced the appointment of Cristian Massacesi as executive vice president, chief medical officer, and head …
Neuraxpharm appoints Avendran Naidu as head of commercial upon launch of Australian affiliate
July 28, 2025Manufacturing and Production, Research and Development Neuraxpharm, Neuraxpharm Australia, Neurology, central nervous system, multiple sclerosis
Neuraxpharm Group has announced the launch of Neuraxpharm Australia, furthering its global expansion beyond Europe and into key international markets. …
Seaport Therapeutics doses first patient in trial of GlyphAllo for depression
July 25, 2025Research and Development Psychiatry, Seaport Therapeutics, clinical trial, major depressive disorder, mental health, neuropsychiatric conditions
Seaport Therapeutics has dosed its first patient in its phase 2b BUOY-1 study of GlyphAllo (SPT-300), an oral prodrug of …
Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans
July 25, 2025Mergers and Acquisitions, Research and Development CEO, Corporate, Cube Biotech, IBA Lifescience, archimed, executive chairman
Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein …
PureTech Health appoints interim CEO Robert Lyne
July 24, 2025Research and Development Corporate, PureTech Health, board of directors, chief portfolio officer, interim CEO
PureTech Health has announced the departure of chief executive officer (CEO) Bharatt Chowrira, who has stepped down from his role …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
